These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 18683125)

  • 1. Sinomenine versus NSAIDs for the treatment of rheumatoid arthritis: a systematic review and meta-analysis.
    Xu M; Liu L; Qi C; Deng B; Cai X
    Planta Med; 2008 Oct; 74(12):1423-9. PubMed ID: 18683125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects and safety of Sinomenine in treatment of rheumatoid arthritis contrast to methotrexate: a systematic review and Meta-analysis.
    Liu W; Qian X; Ji W; Lu Y; Wei G; Wang Y
    J Tradit Chin Med; 2016 Oct; 36(5):564-77. PubMed ID: 29932627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Meta-analysis of efficacy and safety of sinomenine combined with methotrexate in treatment of rheumatoid arthritis].
    Zeng C; Shuai YF; Li X
    Zhongguo Zhong Yao Za Zhi; 2021 Jan; 46(1):214-224. PubMed ID: 33645073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological mechanisms of sinomenine in anti-inflammatory immunity and osteoprotection in rheumatoid arthritis: A systematic review.
    Li JM; Yao YD; Luo JF; Liu JX; Lu LL; Liu ZQ; Dong Y; Xie Y; Zhou H
    Phytomedicine; 2023 Dec; 121():155114. PubMed ID: 37816287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-amorphous systems of sinomenine with nonsteroidal anti-inflammatory drugs: A strategy for solubility improvement, sustained release, and drug combination therapy against rheumatoid arthritis.
    Chen X; Li D; Zhang H; Duan Y; Huang Y
    Int J Pharm; 2021 Sep; 606():120894. PubMed ID: 34280485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A network pharmacology approach to explore the potential targets underlying the effect of sinomenine on rheumatoid arthritis.
    Guo X; Ji J; Feng Z; Hou X; Luo Y; Mei Z
    Int Immunopharmacol; 2020 Mar; 80():106201. PubMed ID: 31972421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A combination of sinomenine and methotrexate reduces joint damage of collagen induced arthritis in rats by modulating osteoclast-related cytokines.
    Sun Y; Yao Y; Ding CZ
    Int Immunopharmacol; 2014 Jan; 18(1):135-41. PubMed ID: 24287449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of nonsteroidal antiinflammatory drugs on the C-reactive protein level in rheumatoid arthritis: a meta-analysis of randomized controlled trials.
    Tarp S; Bartels EM; Bliddal H; Furst DE; Boers M; Danneskiold-Samsøe B; Rasmussen M; Christensen R
    Arthritis Rheum; 2012 Nov; 64(11):3511-21. PubMed ID: 22833186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppressing mPGES-1 expression by sinomenine ameliorates inflammation and arthritis.
    Zhou H; Liu JX; Luo JF; Cheng CS; Leung EL; Li Y; Su XH; Liu ZQ; Chen TB; Duan FG; Dong Y; Zuo YH; Li C; Lio CK; Li T; Luo P; Xie Y; Yao XJ; Wang PX; Liu L
    Biochem Pharmacol; 2017 Oct; 142():133-144. PubMed ID: 28711625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular safety of lumiracoxib: a meta-analysis of all randomized controlled trials > or =1 week and up to 1 year in duration of patients with osteoarthritis and rheumatoid arthritis.
    Matchaba P; Gitton X; Krammer G; Ehrsam E; Sloan VS; Olson M; Mellein B; Hoexter G; Orloff J; Garaud JJ
    Clin Ther; 2005 Aug; 27(8):1196-214. PubMed ID: 16199245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of sinomenine for diabetic kidney diseases: A meta-analysis.
    Zhang YJ; Shang ZJ; Zheng M; Shi R
    Medicine (Baltimore); 2023 Dec; 102(52):e36779. PubMed ID: 38206710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of Duhuo-Jisheng decoction in rheumatoid arthritis: A systematic review and meta-analysis of 42 randomized controlled trials.
    Qu P; Wang H; Wang W; Du S; Peng Z; Hu Q; Tang X
    Medicine (Baltimore); 2023 Nov; 102(44):e35513. PubMed ID: 37933004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sinomenine inhibits fibroblast-like synoviocyte proliferation by regulating α7nAChR expression via ERK/Egr-1 pathway.
    Yi L; Lyn YJ; Peng C; Zhu RL; Bai SS; Liu L; Wang PX; Zhou H; Dong Y
    Int Immunopharmacol; 2018 Mar; 56():65-70. PubMed ID: 29367088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NSAIDS or paracetamol, alone or combined with opioids, for cancer pain.
    McNicol E; Strassels SA; Goudas L; Lau J; Carr DB
    Cochrane Database Syst Rev; 2005 Jan; (1):CD005180. PubMed ID: 15654708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term low-dose corticosteroids vs placebo and nonsteroidal antiinflammatory drugs in rheumatoid arthritis.
    Gotzsche PC; Johansen HK
    Cochrane Database Syst Rev; 2003; (1):CD000189. PubMed ID: 12535392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Research advances of mechanism of sinomenine in treating rheumatoid arthritis].
    Zhang YL; Ouyang GL; Xiao LB
    Zhong Xi Yi Jie He Xue Bao; 2009 Aug; 7(8):775-8. PubMed ID: 19671418
    [No Abstract]   [Full Text] [Related]  

  • 17. Short-term low-dose corticosteroids vs placebo and nonsteroidal antiinflammatory drugs in rheumatoid arthritis.
    Gotzsche PC; Johansen HK
    Cochrane Database Syst Rev; 2002; (2):CD000189. PubMed ID: 12076385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New directions in symptomatic therapy for patients with osteoarthritis and rheumatoid arthritis.
    Hochberg MC
    Semin Arthritis Rheum; 2002 Dec; 32(3 Suppl 1):4-14. PubMed ID: 12528069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pivotal factors for successful withdrawal of nonsteroidal anti-inflammatory drugs in rheumatoid arthritis patients in remission or with low-disease activity.
    Go DJ; Shin K; Baek HJ; Kang SW; Kang YM; Jun JB; Lee YJ; Park SH; Song YW
    Clin Rheumatol; 2018 Feb; 37(2):307-314. PubMed ID: 28988296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis: cyclooxygenase-2 inhibitors are no better than nonselective nonsteroidal anti-inflammatory drugs with proton pump inhibitors in regard to gastrointestinal adverse events in osteoarthritis and rheumatoid arthritis.
    Wang X; Tian HJ; Yang HK; Wanyan P; Peng YJ
    Eur J Gastroenterol Hepatol; 2011 Oct; 23(10):876-80. PubMed ID: 21900785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.